| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680348 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2017 | 13 Pages |
Abstract
These data suggest that apoJ may have potential in the context of use (COU) of AD diagnostics, I-309 may be specifically useful in the COU of identifying individuals at greatest risk for progressing toward AD. This work takes an initial step toward identifying blood biomarkers with potential use in the diagnosis and prognosis of AD and should be validated across other prospective cohorts.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Veer Bala Gupta, Eugene Hone, Steve Pedrini, James Doecke, Sid O'Bryant, Ian James, Ashley I. Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Ralph N. Martins, AIBL Research Group AIBL Research Group,